Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of 3.29% is 157% above its 5-year average of 1.28%, near the high end of its 5-year range (-68.29%–3.29%).
As of the fiscal period ended Tuesday, June 30, 2026. 30.40% above its 12-month average of 2.53%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q1 FY2027 (2026-06-30): 3.29%.
RETURN ON INVESTED CAPITAL (ROIC)
3.29%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
2.53%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-19.39%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
1.28%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
1.67%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
5.99%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
8.70%
CURRENT VS TTM AVG
+30.40%
CURRENT VS 3Y AVG
+116.99%
CURRENT VS 5Y AVG
+156.53%
CURRENT VS 10Y AVG
+97.33%
CURRENT VS 15Y AVG
-45.04%
CURRENT VS 20Y AVG
-62.11%
SECTOR MEDIAN · HEALTHCARE
-32.73%
median of 625 covered companies
CURRENT VS SECTOR MEDIAN
+110.07%
vs the sector median at left
Mesa Laboratories, Inc.
Market Cap
$764.06M
Return on Invested Capital (ROIC)
3.29%
TTM Avg
2.53%
3Y Avg
-19.39%
5Y Avg
1.28%
Market Cap
$765.72M
Return on Invested Capital (ROIC)
-38.92%
TTM Avg
-31.45%
3Y Avg
-27.82%
5Y Avg
-24.27%
Market Cap
$755.18M
Return on Invested Capital (ROIC)
-42.83%
TTM Avg
-51.53%
3Y Avg
-51.53%
5Y Avg
-51.53%
Market Cap
$755.50M
Return on Invested Capital (ROIC)
-36.83%
TTM Avg
-41.75%
3Y Avg
-59.42%
5Y Avg
-51.49%
Market Cap
$781.78M
Return on Invested Capital (ROIC)
-23.16%
TTM Avg
-53.28%
3Y Avg
-63.06%
5Y Avg
-59.41%
Market Cap
$789.07M
Return on Invested Capital (ROIC)
-8.34%
TTM Avg
-22.82%
3Y Avg
-51.67%
5Y Avg
-50.32%
Market Cap
$785.93M
Return on Invested Capital (ROIC)
-0.26%
TTM Avg
4.90%
3Y Avg
-0.53%
5Y Avg
1.15%
Market Cap
$735.04M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-136.50%
3Y Avg
-154.74%
5Y Avg
-122.58%
Market Cap
$794.93M
Return on Invested Capital (ROIC)
-9.77%
TTM Avg
8.57%
3Y Avg
-11.39%
5Y Avg
-51.99%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Mesa Laboratories, Inc. (MLAB) | $764.06M | 3.29% | 2.53% | -19.39% | 1.28% |
| Design Therapeutics, Inc. (DSGN)vs › | $765.72M | -38.92% | -31.45% | -27.82% | -24.27% |
| Attovia Therapeutics, Inc. (ATTO)vs › | $755.18M | -42.83% | -51.53% | -51.53% | -51.53% |
| Candel Therapeutics, Inc. (CADL)vs › | $755.50M | -36.83% | -41.75% | -59.42% | -51.49% |
| Lexicon Pharmaceuticals, Inc. (LXRX)vs › | $781.78M | -23.16% | -53.28% | -63.06% | -59.41% |
| Geron Corporation (GERN)vs › | $789.07M | -8.34% | -22.82% | -51.67% | -50.32% |
| AdaptHealth Corp. (AHCO)vs › | $785.93M | -0.26% | 4.90% | -0.53% | 1.15% |
| Achieve Life Sciences, Inc. (ACHV)vs › | $735.04M | N/A | -136.50% | -154.74% | -122.58% |
| Gyre Therapeutics, Inc. (GYRE)vs › | $794.93M | -9.77% | 8.57% | -11.39% | -51.99% |
| Cytek Biosciences, Inc. (CTKB)vs › | $726.43M | -12.00% | -7.53% | -5.45% | -2.27% |
ROIC
3.3%
ROE
2.5%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | 3.29% |
| 2026-03-31 | 2.78% |
| 2025-12-31 | 2.46% |
| 2025-09-30 | 2.14% |
| 2025-06-30 | 1.96% |
| 2025-03-31 | 2.43% |
| 2024-12-31 | -67.09% |
| 2024-09-30 | -65.30% |
| 2024-06-30 | -68.29% |
| 2024-03-31 | -67.60% |
| 2023-12-31 | -0.04% |
| 2023-09-30 | 0.53% |
| 2023-06-30 | 0.66% |
| 2023-03-31 | 0.54% |
| 2022-12-31 | 0.43% |
| 2022-09-30 | -0.52% |
| 2022-06-30 | -0.47% |
| 2022-03-31 | 0.39% |
| 2021-12-31 | 1.20% |
| 2021-09-30 | 1.99% |
| 2021-06-30 | 2.06% |
| 2021-03-31 | 2.17% |
| 2020-12-31 | 1.51% |
| 2020-09-30 | 1.00% |
| 2020-06-30 | 1.06% |
| 2020-03-31 | 1.08% |
| 2019-12-31 | 1.83% |
| 2019-09-30 | 3.09% |
| 2019-06-30 | 6.07% |
| 2019-03-31 | 6.28% |
| 2018-12-31 | 7.86% |
| 2018-09-30 | 0.95% |
| 2018-06-30 | 1.85% |
| 2018-03-31 | 0.81% |
| 2017-12-31 | 0.57% |
| 2017-09-30 | 7.71% |
| 2017-06-30 | 8.12% |
| 2017-03-31 | 8.16% |
| 2016-12-31 | 8.51% |
| 2016-09-30 | 8.03% |
| 2016-06-30 | 7.56% |
| 2016-03-31 | 7.82% |
| 2015-12-31 | 6.73% |
| 2015-09-30 | 6.68% |
| 2015-06-30 | 9.61% |
| 2015-03-31 | 9.37% |
| 2014-12-31 | 9.70% |
| 2014-09-30 | 9.56% |
| 2014-06-30 | 8.13% |
| 2014-03-31 | 9.27% |
| 2013-12-31 | 9.67% |
| 2013-09-30 | 12.56% |
| 2013-06-30 | 13.70% |
| 2013-03-31 | 13.93% |
| 2012-12-31 | 13.67% |
| 2012-09-30 | 17.79% |
| 2012-06-30 | 13.64% |
| 2012-03-31 | 17.26% |
| 2011-12-31 | 17.18% |
| 2011-09-30 | 15.44% |
| 2011-06-30 | 13.95% |
| 2011-03-31 | 13.57% |
| 2010-12-31 | 12.29% |
| 2010-09-30 | 12.95% |
| 2010-06-30 | 12.64% |
| 2010-03-31 | 14.98% |
| 2009-12-31 | 15.33% |
| 2009-09-30 | 15.64% |
| 2009-06-30 | 16.49% |
| 2009-03-31 | 16.83% |
| 2008-12-31 | 17.51% |
| 2008-09-30 | 17.73% |
| 2008-06-30 | 18.17% |
| 2008-03-31 | 18.73% |
| 2007-12-31 | 20.59% |
| 2007-09-30 | 19.88% |
| 2007-06-30 | 19.09% |
| 2007-03-31 | 18.53% |
| 2006-12-31 | 16.23% |
| 2006-09-30 | 15.42% |
| 2006-06-30 | 15.32% |
| 2006-03-31 | 17.57% |
| 2005-12-31 | 16.42% |
| 2005-09-30 | 15.58% |
| 2005-06-30 | 13.51% |
| 2005-03-31 | 14.40% |
| 2004-12-31 | 14.77% |
| 2004-09-30 | 13.60% |
| 2004-06-30 | 13.77% |
| 2004-03-31 | 13.47% |
| 2003-12-31 | 13.19% |
| 2003-09-30 | 13.53% |
| 2003-06-30 | 14.72% |
